Literature DB >> 24578598

Aortic valve replacement in children: Options and outcomes.

Bahaaldin Alsoufi1.   

Abstract

Several disease pathologies such as congenital heart disease and rheumatic fever can affect the aortic valve (AV) in children frequently necessitating intervention. While percutaneous or surgical AV repair is recommended as initial management strategy in children with AV disease, AV replacement (AVR) might become necessary in children with significant valve destruction and after repair or intervention failure. AVR in children is associated with distinct clinical and technical problems owing to several anatomic, social and prosthesis-related issues. In the current review, we list different AV substitutes, discuss their advantages and shortcomings, outline AVR results in children, and explore the divergence of outcomes in various age, anatomy and pathology subgroups; all in the aim to identify optimal AVR choice for each patient taking into consideration his unique anatomic and demographic characteristics.

Entities:  

Keywords:  Aortic valve replacement; Congenital heart disease; Mechanical valves; Rheumatic fever; Ross procedure

Year:  2013        PMID: 24578598      PMCID: PMC3936244          DOI: 10.1016/j.jsha.2013.11.003

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  58 in total

1.  Serial echocardiographic measurements of the pulmonary autograft in the aortic valve position after the Ross operation in a pediatric population using normal pulmonary artery dimensions as the reference standard.

Authors:  D E Solowiejczyk; F Bourlon; H D Apfel; A J Hordof; D T Hsu; G Crabtree; M Galantowicz; W M Gersony; J M Quaegebeur
Journal:  Am J Cardiol       Date:  2000-05-01       Impact factor: 2.778

2.  Modified Ross procedure to prevent autograft dilatation.

Authors:  Ross M Ungerleider; Yoshio Ootaki; Irving Shen; Karl F Welke
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

3.  Fate of the aortic root late after Ross operation.

Authors:  Giovanni Battista Luciani; Gianluca Casali; Alessandro Favaro; Maria Antonia Prioli; Luca Barozzi; Francesco Santini; Alessandro Mazzucco
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

4.  Anticoagulation in children with mechanical valve prostheses.

Authors:  S M Bradley; R M Sade; F A Crawford; M R Stroud
Journal:  Ann Thorac Surg       Date:  1997-07       Impact factor: 4.330

5.  Outcomes and associated risk factors for aortic valve replacement in 160 children: a competing-risks analysis.

Authors:  Tara Karamlou; Karen Jang; William G Williams; Christopher A Caldarone; Glen Van Arsdell; John G Coles; Brian W McCrindle
Journal:  Circulation       Date:  2005-11-29       Impact factor: 29.690

6.  Intermediate-term results of the Ross procedure in neonates and infants.

Authors:  Takeshi Shinkawa; Edward L Bove; Jennifer C Hirsch; Eric J Devaney; Richard G Ohye
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

7.  Valve sparing aortic root replacement for dilatation of the pulmonary autograft and aortic regurgitation after the Ross procedure.

Authors:  Toru Ishizaka; Eric J Devaney; Stephen R Ramsburgh; Takaaki Suzuki; Richard G Ohye; Edward L Bove
Journal:  Ann Thorac Surg       Date:  2003-05       Impact factor: 4.330

8.  Ross and Yasui operations for complex biventricular repair in infants with critical left ventricular outflow tract obstruction.

Authors:  Edward J Hickey; Thomas Yeh; Jeffrey P Jacobs; Christopher A Caldarone; Christo I Tchervenkov; Brian W McCrindle; Francois Lacour-Gayet; Christian Pizarro
Journal:  Eur J Cardiothorac Surg       Date:  2009-09-17       Impact factor: 4.191

9.  Pulmonary autograft in children: realized growth potential.

Authors:  R C Elkins; C J Knott-Craig; K E Ward; C McCue; M M Lane
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

10.  Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?

Authors:  Bahaaldin Alsoufi; Cedric Manlhiot; Brian W McCrindle; Charles C Canver; Ahmed Sallehuddin; Saud Al-Oufi; Mansour Joufan; Zohair Al-Halees
Journal:  Eur J Cardiothorac Surg       Date:  2009-04-14       Impact factor: 4.191

View more
  7 in total

Review 1.  Heart Valve Replacements with Regenerative Capacity.

Authors:  Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

2.  Human iPSC-derived mesenchymal stem cells encapsulated in PEGDA hydrogels mature into valve interstitial-like cells.

Authors:  Aline L Y Nachlas; Siyi Li; Rajneesh Jha; Monalisa Singh; Chunhui Xu; Michael E Davis
Journal:  Acta Biomater       Date:  2018-03-02       Impact factor: 8.947

Review 3.  Stem cell therapy and tissue engineering for correction of congenital heart disease.

Authors:  Elisa Avolio; Massimo Caputo; Paolo Madeddu
Journal:  Front Cell Dev Biol       Date:  2015-06-30

4.  Congenital aortic stenosis due to unicuspid unicommissural aortic valve: a case report.

Authors:  Arnar B Ingason; Gunnlaugur Sigfusson; Bjarni Torfason
Journal:  J Cardiothorac Surg       Date:  2018-06-07       Impact factor: 1.637

5.  Long-term outcomes after the paediatric Ross and Ross-Konno procedures.

Authors:  Johanna Schlein; Barbara Elisabeth Ebner; Ralf Geiger; Paul Simon; Gregor Wollenek; Anton Moritz; Andreas Gamillscheg; Eva Base; Günther Laufer; Daniel Zimpfer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18

6.  Incorporating nanocrystalline cellulose into a multifunctional hydrogel for heart valve tissue engineering applications.

Authors:  Nianfang Ma; Daniel Y Cheung; Jonathan T Butcher
Journal:  J Biomed Mater Res A       Date:  2021-07-13       Impact factor: 4.854

Review 7.  Aortic valve surgery: management and outcomes in the paediatric population.

Authors:  Mariam Zaidi; Ganeshkumar Premkumar; Rimel Naqvi; Arwa Khashkhusha; Zahra Aslam; Adil Ali; Abdulla Tarmahomed; Amr Ashry; Amer Harky
Journal:  Eur J Pediatr       Date:  2021-05-10       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.